Related Experiment Video
Updated: May 9, 2025

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Healing from the Peel: Exploring the Bioactive Potential of Bananas for Gastric Ulcer Management
R Lizeth P Muñoz1, Carolina P Mora1, Laura V Parra-Perdomo1
1Departamento de Ciencias Químicas y Farmacéuticas, Facultad Barberi de Ingeniería, Diseño y Ciencias Aplicadas, Grupo de Investigación Natura, Universidad Icesi, Calle 18 No. 122-135, 760031 Cali, Colombia.
Abstract:
Bananas (Musaceae), herbaceous plants widely cultivated in tropical and subtropical regions, are traditionally used for their purported therapeutic effects on early-stage gastric ulcers. This comprehensive review provides an analysis of the bioactive compounds in bananas, with a focus on the influence of varietal differences and ripening stages. Researchers have identified key bioactive molecules in bananas, including phenolic compounds, carotenoids, and biogenic amines, predominantly located in the banana peel. Unripe bananas contain higher levels of phenolic compounds and biogenic amines, whereas ripened bananas exhibit increased carotenoid content. Additionally, in vivo studies have indicated that flavonoids, particularly leucocyanidin, exert gastroprotective effects by enhancing gastric mucosal thickness and increasing epidermal growth factor receptor expression, which promotes angiogenesis and re-epithelialization of the gastric mucosa, thereby protecting against ulcer formation. The findings reinforce the medicinal value of bananas, particularly in their unripe state, and highlight the importance of further exploration into their bioactive components for the development of natural therapies targeting gastric health.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

